Table 2.
Epitopea | Position (amino acid) | Epitope sequence (based on Sal-1) | S | Si | Pa | K | H | Hd ± SD | π ± SD | dN − dS | Taj D | D* (F&L) | F* (F&L) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
H1 | 306–321 | FHRDITFRKLYLKRKL | 1 | 0 | 1 | 0.3 | 2 | 0.28 ± 0.077 | 0.00593 ± 0.001 | 0.007 | 0.31 | 0.55 | 0.56 |
H2 | 328–341 | EGDLLLKLNNYRYN | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
H3 | 384–399 | DEKAQQRRKQWWNESK | 5 | 0 | 5 | 1.6 | 6 | 0.81 ± 0.020 | 0.0341 ± 0.002 | 1.99b | 1.68 | 1.11 | 1.27 |
M1 | 344–355 | FCKDIRWSLGDF | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
M2 | 414–429 | LKGNFIWICKLNVAVN | 2 | 0 | 2 | 0.6 | 3 | 0.401 ± 0.085 | 0.012 ± 0.002 | 1.36 | 0.48 | 0.48 | 0.76 |
M 3 | 432–447 | PQIYRWIREWGRDYVS | 2 | 0 | 2 | 0.5 | 4 | 0.452 ± 0.078 | 0.010 ± 0.002 | 0.02 | 0.17 | 0.76 | 0.68 |
L2 | 400–411 | AQIWTAMMYSVK | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
L3 | 364–377 | MEGIGYSKVVENNL | 1 | 0 | 1 | 0.5 | 2 | 0.511 ± 0.019 | 0.011 ± 0.0004 | 1.1 | 1.68 | 0.55 | 1.01 |
L1 | 282–293 | CIPDRRYQLCMK | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
L4 | 272–286 | DWDCNTKKDVCIPD | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
a[18]; b p < 0.02; S = number of variable (segregating) sites, Si = singleton variable sites, Pa = parsimony informative sites, K = average number of pair-wise nucleotide differences, H = number of haplotypes, Hd = haplotype diversity, SD = standard deviation, π = nucleotide diversity, dN = non synonymous substitution, dS = synonymous substitution, D⁄(F&L) = Fu and Li’s D⁄ test statistic, F⁄(F&L) = Fu and Li’s F⁄ test statistic. Bold and underline indicate polymorphic amino acid residues